770 ADU-1604, a novel CTLA-4 blocking antibody modulates pharmacodynamic markers in PD1 relapse/refractory melanoma patients

Similar Items

• Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
  by: Sara Valpione, et al.
  Published: (2018-04-01)
• Microsatellite based genetic characterization of Kanni Adu, Kodi Adu and Salem Black goats of Tamil Nadu
  by: M JEYAKUMAR, et al.
  Published: (2014-09-01)
• Search for the radiative decay D s + → γρ 770 + $$ {D}_s^{+}\to \gamma \rho {(770)}^{+} $$
  by: The BESIII collaboration, et al.
  Published: (2024-11-01)
• ADU 613 - INTERNATIONAL ACCOUNTING APRIL 08.
  by: PPP, Pusat Pengajian Pengurusan
  Published: (2008)
• Isolation and characterization of Brochothrix phage ADU4
  by: Abdulkerim Karaynir, et al.
  Published: (2022-11-01)